Integrated Capecitabine-Temozolomide with Radioembolization for Liver-Dominant G2 NETs: Long-Term Outcomes of a Single-Institution Retrospective Study.
Michael C SoulenUrsina R TeitelbaumRosemarie MickJennifer EadsJeffrey I MondscheinMandeep DagliDiana van HoutenNevena DamjanovCharles SchneiderKeith CengelDavid C MetzPublished in: Cardiovascular and interventional radiology (2023)
Chemoradiation with CapTem and TARE provided durable control of G2 NET liver metastases for substantially longer than expectations for embolotherapy or chemotherapy alone.